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Abstract: Matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) is a 
powerful tool that enables the simultaneous detection and identification of biomolecules in 
analytes.  MALDI-imaging  mass  spectrometry  (MALDI-IMS)  is  a  two-dimensional 
MALDI-mass  spectrometric  technique  used  to  visualize  the  spatial  distribution  of 
biomolecules without extraction, purification, separation, or labeling of biological samples. 
MALDI-IMS has revealed the characteristic distribution of several biomolecules, including 
proteins, peptides, amino acids, lipids, carbohydrates, and nucleotides, in various tissues. 
The versatility of MALDI-IMS has opened a new frontier in several fields such as medicine, 
agriculture, biology, pharmacology, and pathology. MALDI-IMS has a great potential for 
discovery  of  unknown  biomarkers.  In  this  review,  we  describe  the  methodology  and 
applications of MALDI-IMS for biological samples. 
Keywords: imaging mass spectrometry; matrix-assisted laser desorption/ionization mass 
spectrometry; biomarker; protein; lipids 
 
1. Overview 
Imaging  mass  spectrometry  (IMS)  is  a  relatively  new  imaging  method  based  on  mass  
spectrometry (MS). MS is an analytical technique that detects the mass-to-charge ratio (m/z) of ionized 
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molecules. The application of several ionization methods, including secondary ion mass spectrometry 
(SIMS)  [1],  desorption  electrospray  ionization  (DESI)  [2],  and  matrix-assisted  laser 
desorption/ionization (MALDI) [3], has been investigated for IMS. MALDI-MS is a powerful method 
that allows the simultaneous detection and identification of many molecules directly from biological 
sections  [4,5].  MALDI-MS  can  detect  a  wide  range  of  biomolecules  ranging  from  
small (m/z < 1000) [6] to large molecules (m/z > 100 kDa) [7]. Due to the widespread applicability of 
this  method,  MALDI-MS  is  widely  used  in  various  fields,  such  as  proteomics  [8–10],  
lipidomics  [11–18],  metabolomics  [19,20],  and  glycomics  [21,22].  In  this  review,  we  focus  on 
molecular imaging by MALDI-MS (MALDI-IMS), a two-dimensional MALDI-MS technique that is 
used to visualize the spatial distribution of biomolecules in biological sections (Figure 1) [23–30]. 
Samples for MALDI-IMS can be obtained from any type of organism, ranging from bacteria and plants 
to animal and human tissues. The versatility of MALDI-IMS has opened a new frontier in several fields, 
including medicine, agriculture, biology, pharmacology, and pathology.  
Figure 1. Schema of biomarker discovery using MALDI-IMS. Thin-section samples are 
mounted on a plate (a), coated with matrix (b), and measured by a mass spectrometer (c). 
Obtained mass spectra (d) are used for a data mining approach (e). Molecules of interest 
can be visualized (f) and identified by MS/MS of tissues (g). 
 
The important features that make MALDI-IMS a practical tool in a wide range of life sciences are 
its  molecular  identification  capability  and  label-free  biomolecular  simultaneous  imaging.  These 
features of MALDI-IMS provide the scientific community with a new strategy for biomarker discovery. 
This  new  non-targeting  screening  method  has  proven  useful  for  discovering  unknown  biomarkers  
[31–33].  In  this  review,  we  describe  the  methodology  and  applications  of  MALDI-IMS  for  
biological samples. 
2. Methodology 
The important experimental steps for visualizing endogenous molecules by using MALDI-IMS are 
sample preparation, matrix application, measurement, and data analysis. In this section, we describe the 
basic experimental MALDI-IMS procedure. Int. J. Mol. Sci. 2010, 11                       
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2.1. Biological Sample Preparation 
Optimization  of  the  sample  preparation  procedure  according  to  the  characteristic  chemical  and 
physical  properties  of  each  analyte  is  important.  The  sample  preparation  procedure  needs  to  be 
controlled to obtain meaningful images of endogenous molecules in the microdomain of biological 
sections. Here, we discuss crucial preparation steps, including sample fixation, embedding, sectioning, 
and washing. 
2.1.1. Fixation and Embedding  
The most preferred samples for MALDI-IMS are fresh or frozen and chemically unmodified tissues. 
Fresh-frozen tissues can be prepared using powdered dry ice, liquid nitrogen, liquid nitrogen-chilled 
isopentane, etc. Among these fresh-freezing methods, the tissue section morphology appears to be 
well-maintained when samples are frozen by liquid nitrogen-chilled isopentane, which is used to freeze 
biopsy samples in clinical practice [34]. However, the optimal freezing method differs for different 
samples. It is important to ensure that tissue section morphology is well maintained.  
Embedding of the tissue samples in supporting material, such as an optimal cutting temperature 
(OCT) compound, allows maintenance of tissue morphology and precise sample sectioning. However, 
supporting  materials  are  often  ionized  during  MALDI-MS  analysis  and  sometimes  act  as  ion 
suppressors  of  molecules  of  interest  [35].  Therefore,  samples  should  not  be  embedded  if  precise 
sample sections can be prepared without embedding. When it is difficult to prepare a sample section, 
the use of carboxymethylcellulose (CMC) or gelatin as embedding material is recommended. Sodium 
CMC (2%) is reported to be used as an alternative embedding compound that does not interfere with 
the detection sensitivity of biomolecules in MALDI-IMS analysis [36,37]. Chen et al. reported that 
gelatin provided a cleaner signal background compared to that provided by OCT [38]. Researchers 
should ensure suitability between the supporting material and the biomolecules of interest. 
Formaldehyde fixation and paraffin embedding, the most commonly used preservation technique, 
has limited use in IMS. Formaldehyde fixation makes IMS analysis difficult because of the protein 
cross-linking induced by formaldehyde. The on-tissue proteolytic digestion method, in which proteins 
are denatured and digested by enzymes, has been developed in order to address this problem [9,39]. 
The protocol for this approach was recently published [40], and the method includes an indispensable 
paraffin removal step involving the use of xylene and ethanol. Lipophilic molecules are lost during this 
deparaffinization step; therefore, formaldehyde-fixed and paraffin-embedded (FFPE) samples cannot 
be used for lipid imaging. 
2.1.2. Sectioning  
Ionization efficiency is partly dependent on the thickness of the tissue section  [41]. In general,  
5–20-μm-thick sections are prepared for the analysis of low molecular weight molecules. The use of 
thinner tissue sections (2–5 μm thick) has been recommended for the analysis of high molecular weight 
molecules (range, 3–21 kDa) [42]. Sections are thaw-mounted on a stainless steel conductive stage or 
on  commercially  available  indium-tin  oxide  (ITO)-coated  glass  slides.  We  recommend  the  use  of  
ITO-coated glass slides because these transparent slides enable microscopic observation of the section Int. J. Mol. Sci. 2010, 11                       
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after MALDI-IMS. Adhesive film can be used instead of thaw-mounting on the ITO-coated glass slides 
[36]. Use of adhesive film is suitable for samples for which thaw-mounted preparation of sections is 
challenging (e.g., rice kernel, bone, or whole-body sections) [43]. 
2.1.3. Washing  
Washing is required for peptide or protein analysis because their detection is often prevented by 
large amounts of easily ionized lipid species. Lipid removal simplifies mass spectra in the range of  
m/z 400–1000; thus, lipid removal enables the detection of low mass peptides that are usually masked 
by lipid peaks. The washing method should be optimized for the target imaging molecules. Several 
washing protocols using organic solvents have been reported [9,35,44–46]. Washing is also required 
after MALDI-IMS for removing the staining matrix. The matrix can be removed by the solvent after 
IMS.  For  example,  2,5-dihydroxybenzoic  acid  (DHB)  can  be  removed  by  methanol.  After  
MALDI-IMS completion and matrix removal, tissue samples can be stained with hematoxylin-eosin. 
2.2. Matrix Application 
The matrix plays a central role in MALDI-MS soft ionization [4,5]. Biomolecules are softly ionized 
in the co-crystal with the matrix, which absorbs the laser beam energy and protects biomolecules from 
the  disruptive  energy.  Protonated  ion  ([M + H]
+)  or  deprotonated  ion  ([M − H]
−)  molecules  are 
generally detected. Sodium adduct ion ([M + Na]
+) and potassium adduct ion ([M + K]
+) are often 
observed by biological sample analysis. It is very important to choose appropriate matrices to obtain 
meaningful biomolecule images. An overview of the matrices used for IMS can also be found in other 
reviews [30,47]. 
2.2.1. Choice of Matrix  
The choice of matrix used for MALDI-IMS depends on the mass range and chemical properties of 
the analytes. Among the many kinds of matrices, sinapinic acid (3,5-dimethoxy-4-hydroxycinnamic 
acid  [SA])  is  generally  used  for  high-weight  molecules  such  as  proteins,  while  
α-cyano-4-hydroxycinnamic acid (CHCA) is often used for middle-weight molecules such as peptides. 
DHB or 9-aminoacridine (9-AA) is generally used for low molecular weight molecules such as lipids 
or metabolites. DHB appears to be suitable for analysis in the positive-ion mode, while 9-AA tends to 
be appropriate for analysis in the negative-ion mode.  
The development of new matrices is still being reported. Ours and other research groups recently 
reported  the  use of nanoparticles  as  new matrices  [48–52]. For example, iron oxide nanoparticles 
enable the visualization of sulfatide and phospholipid distribution [22,53], silver nanoparticles can be 
used  for  the  analysis  of  fatty  acids  [50],  and  gold  nanoparticles  are  appropriate  for  the  sensitive 
detection of glycosphingolipids such as sulfatide and ganglioside [54].  
2.2.2. Matrix Application Methods  
Three kinds of matrix application methods are generally used. The first method involves manual 
spraying using thin layer chromatography (TLC) sprayers or airbrushes [55]. This method should be 
performed at a constant room temperature and at low humidity to ensure homogeneous application of Int. J. Mol. Sci. 2010, 11                       
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the matrix. By applying this method, tissue sections can be quickly and inexpensively coated with 
relatively  small  crystals.  However,  this  method  requires  skill.  The  second  method  is  automatic 
depositing of small droplets of matrix solution with robotic devices such as a chemical inkjet printer 
(ChIP-1000) (Shimadzu Corporation, Kyoto, Japan) [56]. The on-tissue digestion method mentioned 
above can also be performed using the ChIP-1000 instrument. Compared to the droplet spot size in 
manual spraying, the droplet spot size of this method increases the signal sensitivity but decreases the 
spatial resolution (>100–200 μm) [57]. The limitation of the inkjet printer is capillary clogging, which 
occurs when highly concentrated matrix solutions are used. The third method is sublimation of the 
matrix  under  reduced  pressure  and  elevated  temperature  [58].  This  method  requires  no  solvent; 
therefore,  diffusion  of  the  analyte  molecules  during  matrix  application  is  eliminated.  Another 
advantage is the increased purity of the matrix and the formation of very small matrix crystals [59]. 
2.3. Measurement and Data Analysis 
2.3.1. Instruments  
The requirement for performance of IMS is the availability of an x-axis-y-axis moving stage with 
electronic  controls.  Most  modern  MS  instruments  produced  by  major  MS  hardware  companies  
(i.e., Shimadzu, ThermoFisher Scientific, Bruker, Applied Biosystems, Waters) can be adapted for 
MALDI-IMS. Time of flight (TOF) is  the most widely used technology. TOF analyzers allow the 
separation of ionized accelerated molecules according to their mass to charge (m/z) ratio. TOF-MS 
offers suitable performance for MALDI-IMS, namely, good transmission ratio (50–100%), sensitivity, 
mass range, and repetition rate. However, TOF-MS lacks the capability to perform effective tandem 
MS experiments. This disadvantage of TOF-MS changed with the introduction of hybrid analyzers 
such as combination of quadrupole mass analyzer and TOF (so-called qTOF), combination quadrupole 
ion trap (QIT) and TOF (so-called QIT-TOF), combination of ion mobility spectrometry (IMS) and 
TOF (so-called IMS-TOF), or combination of two TOF mass spectrometers (so-called TOF-TOF). 
These  combination  systems  revolutionized  the  application  of  TOF-MS  systems  for  the  structural 
analysis with tandem MS. In general, the first system is used to select a precursor ion for fragmentation, 
while the second TOF system is employed for fragment analysis. Other mass analyzers (and their 
combinations), such as linear ion trap (LIT) [36,60,61], triple quadrupole (QqQ) [62], and Fourier 
transform  ion  cyclotron  resonance  (FTICR)  [63],  are  used  for  MALDI-IMS.  The  advantages  of 
commercially  available  LIT  instruments  are  miniaturization,  capability  of  sample  analysis  on 
nonconductive glass slide MALDI performance at intermediate pressure, and superior performance of 
multistage  MS.  The  QqQ  system  allows  quantitative  analysis  and  single  or  multiple  reaction 
monitoring (SRM/MRM). The FTICR system offers very high mass resolving power and high mass 
measurement accuracy.  
2.3.2. Measurement 
Matrix-coated samples should be measured as soon as possible to avoid biomolecule degradation. 
The procedure to obtain a good MALDI-IMS spectrum is basically the same as that of traditional 
MALDI-MS. Since MALDI-IMS is a two-dimensional MALDI-MS technique, the measurement region 
and  scan  pitch,  which  decide  the  spatial  resolution  of  the  image,  need  to  be  fixed  before  the Int. J. Mol. Sci. 2010, 11                       
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measurement  is  taken.  At  present,  the  finest  spatial  distribution  of  the  commercially  available 
instrument is 10 μm (Mass Microscope Shimadzu) [64,65]. The measurement time depends on the 
number of data spots, the frequency of the laser, the number of shots per spot, and the time required to 
move  the  sample  stage.  For  example,  when  researchers  select  the  region  of  interest  as  a  
1 ×  1 mm
2 area with a 10-μm scan pitch (10,000 data points), it takes about 1 h to complete the 
measurement using a mass microscope equipped with a 1000-Hz laser (100 shots/data point). 
2.3.3. Data Analysis  
A  large  amount  of  data  (a  few  gigabytes)  is  obtained  by  MALDI-IMS;  therefore, visualization 
software packages that can rapidly and efficiently analyze enormous spectra have been developed. 
BioMap  (a  free  software;  Novartis,  Basel,  Switzerland),  FlexImaging  (Bruker  Daltonics,  Bremen, 
Germany), and ImageQuest (Thermo Fisher Scientific, CA, USA) are generally used for visualization. 
For  biomarker  analysis  of  the  MALDI-IMS  dataset,  data  mining  software  such  as  ClinProTools 
(Bruker Daltonics) are typically used [66]. These data mining software effectively reduce the number 
of biomarker candidates.  We previously reported the approach using principal component analysis 
(PCA)  to  discover  different  biomolecules  between  starvation-induced  fatty  livers  and  normal  
livers [55]. Hierarchical clustering was also used to analyze the data obtained from gastric cancer and 
non-neoplastic mucosa tissue sections [67]. 
3. Applications of IMS 
3.1. IMS for Proteins and Peptides 
The proteins present in biological tissue are usually subjected to on-tissue digestion by proteolytic 
enzyme such as trypsin. Groseclose et al. reported the protocol for protein imaging [9]. The method for 
on-tissue protein digestion should include a tissue washing step with organic solvent for removing 
lipids. After lipid removal, a tissue section is spotted with the solution of proteolytic enzyme. Use of a 
chemical inkjet printer (such as ChIP-1000) is suitable for the application of proteolytic enzymes. One 
of the advantages of IMS is its label-free simultaneous visualization of biomolecules. In protein or 
peptide  studies,  the  advantage  of  MALDI-IMS  is  utilized  when  analytes  have  variants  or  when  
non-targeting screening is performed. Stoeckli et al. visualized the amyloid-β peptide species, which is 
generated  by  cleaving  the  amyloid  precursor  protein  at  different  cleavage  sites  [68].  Yao  et  al. 
visualized  the  biomarkers  of  the  neurodegenerative  disease  model  mouse  (Scrapper-knockout  
mouse) [69] using PCA [8]. Applications of MALDI-IMS have been reported in cancer pathology, 
such as human gastric cancer tissues using FFPE samples [56]. MALDI-IMS has been applied in a vast 
spectrum of disease samples and models [39,70–74]. 
Non-digestion approaches have also been reported. This approach was first reported by Caprioli  
et al. [25]. One of the interesting applications for intact proteins directly from tissue sections was 
reported by Dani et al. [10]. They succeeded in the identification of two proteins: an 8 kDa protein that 
matched an unannotated sequence of the Anopheles gambiae genome and odorant binding protein 9 
(OBP-9). A comparison of the peptide profiles of the neurons of the sea slug (Aplysia californica) was 
reported by Rubakhin et al. [75], who revealed distinct peptide profiles for each neuronal subtype.  Int. J. Mol. Sci. 2010, 11                       
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3.2. IMS for Lipids 
IMS  is  currently  the  only  methodology  that  enables  simultaneous  visualization  of  lipids. 
Visualization  of  various  types  of  lipids,  such  as  phospholipids  [23,27,76–79],  sphingolipids  [28], 
glycolipids [13,21,80], and neutral lipids [81], has been reported. In terms of tissue sample preparation, 
formaldehyde  fixation  and  OCT  embedding  are  not  recommended  for  lipid  imaging  because  of  a 
significant reduction in the quality of the mass spectra. Figure 2 shows an example of lipid imaging in 
a biological sample, medaka (Oryzias latipes) [23]. IMS reveals the distribution of lipids in biological 
tissues at the molecular species level. Phosphatidylcholine (PC) (diacyl 16:0/18:1) was observed to be 
localized in the brain and liver, while PC (diacyl 16:0/20:4) was intensely detected in the liver (Figures 
2a and 2b). Molecular lipid species can be identified by MS/MS tissue analyses. A representative 
MS/MS PC spectrum is shown in Figure 3. Neutral loss of the phosphocholine head group (59 and 
183 Da) and fatty acids are usually observed by MS/MS analyses of PC in tissues. Other phospholipid 
species commonly exhibit neutral loss of the head group (43 Da for phosphatidylethanolamine, 162 Da 
for phosphatidylinositol, 87 Da for phosphatidylserine, and 59 and 183 Da for sphingomyelin) on 
MS/MS  spectra  [82].  Neutral  loss  of  fatty  acids  is  observed  in  the  case  of  MS/MS  analyses  for 
triacylglycerol [81]. 
Figure 2. Ion images of phosphatidylcholine (PC) in medaka (Oryzias latipes). Scale bar:  
2 mm. (a) Hematoxylin-eosin staining after MALDI-IMS. (b) Distribution of PC (diacyl 
16:0/18:1). (c) Distribution of PC (diacyl 16:0/20:4). 
 
We recently reported the unique distribution of PC in varicose veins (VVs) [83]. In this study, we 
found arachidonic acid containing PC was localized in the damaged valvular region of VVs, suggesting 
that local inflammation is initiated by the arachidonic acid concentration via an unknown mechanism. 
We further observed this unique lipid distribution pattern in other vascular diseases. Because lipids are 
strongly involved in the onset of vascular diseases [84], abnormal localization of lipids might be a key 
clue in  clarifying the unknown mechanism of vascular disease onset. The use of adhesive film is 
appropriate for arteriosclerotic arteries that have massive calcified regions [36,43]. 
 Int. J. Mol. Sci. 2010, 11                       
 
 
5047 
Figure 3. Phosphatidylcholine (PC) MS/MS spectrum at m/z 798.5. Neutral loss of the PC 
head  group  and  fatty  acids  is  generally observed by MS/MS analysis of phospholipids  
in tissues. 
 
3.3. IMS for Endogenous Metabolites 
MALDI-IMS has  been employed for the detection of endogenous  molecules such as  adenosine 
monophosphate  (AMP),  adenosine  diphosphate  (ADP),  adenosine  triphosphate  (ATP),  and  uridine 
diphosphate (UDP) using 9-AA [85]. Hattori et al. measured the change of ATP, ADP, and AMP in an 
ischemic brain model [86].  
Food nutrients can be visualized by IMS [20,36,82,87,88]. We recently analyzed agricultural and 
marine products and visualized food nutrients such as γ-aminobutyric acid (GABA), essential amino 
acids,  sucrose,  α-tocopherol,  γ-oryzanol,  and  phytic  acid  [36,82,87].  Volatile  components  can  be 
visualized  by  a  mass  microscope  equipped  with  an  atmospheric  pressure  ion-source  chamber 
(Shimadzu) [64]. Figure 4 shows the food nutrients of rice (Oryza sativa) [36]. In this study, we found 
it possible that nutrient distributions are different among rice varieties. The distribution of nutrients 
might  be  used  as  a  biomarker  to  discriminate  the  geographical  origin  of  agricultural  and  marine 
products. A larger-scale study is required to confirm our findings. 
Figure 4. Ion image of nutrients in rice (Oryza sativa). Scale bar: 1 mm. (a) Optical image 
of  a  rice  kernel  (Hinohikari).  (b)  Distribution  of  lysolecithin.  (c)  Distribution  of 
triacylglycerol. (d) Merged image of lysolecithin (red) and triacylglycerol (green). The rice 
kernel section can be prepared using adhesive film.  
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4. Future Perspectives 
MALDI-IMS  is  becoming  an  essential  tool  for  molecular  imaging  of  biological  samples.  
MALDI-IMS  can  facilitate  the  discovery  of  characteristic  molecules  in  regions  of  interest.  The 
advantage of MALDI-IMS—in that it enables us to investigate the localization of known and unknown 
molecules  without  labeling—should  facilitate  biomarker  discovery  and  validation.  To  make  the 
relatively new MALDI-IMS strategy a routine tool for biomarker discovery, it must first be validated in 
a larger-scale sample. A combination of MALDI-IMS and other IMS such as SIMS [1], DESI [2], or 
laser  ablation  inductively  coupled  plasma  mass spectrometry (LA-ICP-MS) [89] is  also  needed to 
overcome the MALDI-IMS limitations. SIMS utilizes a primary ion beam to produce secondary ions 
from  the  surface  of  the  biological  sections  and  is  a  superior  tool  for  high  spatial  resolution  IMS 
(submicron order) of elements and small molecules at the organelle level [90–92]. However, SIMS 
lacks  the  sensitivity  of  the  mass  range  over  m/z  1000  due  to  in-source  fragmentation  as  well  as 
molecular identification ability due to MS/MS incapability. We recently reported that combination use 
of MALDI-IMS and SIMS-IMS complements their respective limitations [93]. DESI is a combination 
of two MS ionization methods, namely electrospray ionization and desorption ionization. DESI uses 
energetic  charged  electrosprayed  solvent  droplets  to  desorb  molecules  from  the  sample  surface. 
Although  the  spatial  resolution  of  DESI-IMS  is  inferior  to  that  of  MALDI-IMS,  
DESI-IMS  allows  for  soft  and  atmospheric  desorption  and  ionization,  which  could  overcome  the 
MALDI-IMS limitation. DESI was applied in several studies including metabolites [94], alkaloids in 
plant [2], and exogenous and endogenous chemicals in latent fingerprints [95]. LA-ICP-MS has been 
developed as a method for imaging elements and is the most sensitive technique for elemental imaging 
of  biological  tissues  [96].  Quantitative  analysis  can  be  performed  by  LA-ICP-MS.  Becker  et  al. 
proposed  the  combined  application  of  LA-ICP-MS  and  MALDI-MS  [96].  We  believe  that  
MALDI-IMS  or  combination  with  alternative  IMS  will  become  an  essential  tool  for  biomarker 
discovery in the near future. 
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